Advertisement
Exelixis, Inc.

Exelixis, Inc. (EXEL) Stock Overview

Explore Exelixis, Inc.โ€™s financial performance, market position, analyst ratings, and future outlook.

EXELโ—NASDAQ
HealthcareBiotechnology
$53.13
$1.39(2.69%)
U.S. Market is Open ยท 14:07
Advertisement

Exelixis, Inc. (EXEL)

Meyka AI Score

Z

Key Financials

Market Cap13.3B
P/E Ratio16.30
EPS (TTM)$3.02
ROE0.40%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year TargetN/A

EXEL Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Exelixis, Inc. (EXEL) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of F, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 61.10, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of N/A.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 16.30 and a market capitalization of 13.3B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.77%
5-Day Change
0.27%
1-Month Change
9.18%
3-Month Change
27.34%
6-Month Change
28.03%
Year-to-Date (YTD) Change
19.96%
1-Year Change
23.66%
3-Year Change
175.43%
5-Year Change
129.11%
All-Time (Max) Change
256.47%

Contact Information

650 837 7000
1851 Harbor Bay Parkway, Alameda, CA, 94502

Company Facts

11,470 Employees
IPO DateApr 17, 2000
CountryUS
Actively Trading

Frequently Asked Questions